| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.779 | 0.002 | 0.779 | Alpha-N-acetylglucosaminidase inhibitor | 0.75 0.003 CID_154699675 | ||
| 0.771 | 0.003 | 0.771 | Alcohol oxidase inhibitor | 0.058 0.038 CID_154699675 | ||
| 0.765 | 0.002 | 0.765 | GABA aminotransferase inhibitor | 0.541 0.002 CID_154699675 | ||
| 0.668 | 0.011 | 0.668 | Aldehyde oxidase inhibitor | |||
| 0.655 | 0.012 | 0.816 | Cholesterol antagonist | 0.816 0.004 CID_154699675 | CID_154699675 | |
| 0.602 | 0.003 | 0.602 | Cystathionine beta-synthase inhibitor | 0.342 0.007 CID_154699675 | ||
| 0.579 | 0.002 | 0.589 | Triose-phosphate isomerase inhibitor | 0.589 0.002 CID_154699675 | CID_154699675 | |
| 0.563 | 0.003 | 0.563 | Glutamate dehydrogenase inhibitor | 0.207 0.009 CID_154699675 | ||
| 0.55 | 0.003 | 0.55 | Porphobilinogen synthase inhibitor | |||
| 0.518 | 0.002 | 0.518 | Keratolytic | 0.151 0.014 CID_154699675 | ||
| 0.518 | 0.005 | 0.518 | Amyloid beta precursor protein antagonist | 0.19 0.064 CID_154699675 | ||
| 0.498 | 0.004 | 0.498 | Aldehyde dehydrogenase inhibitor | 0.294 0.012 CID_154699675 | ||
| 0.492 | 0.004 | 0.492 | GABA C receptor agonist | |||
| 0.489 | 0.003 | 0.489 | Ferrochelatase inhibitor | |||
| 0.477 | 0.004 | 0.477 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.162 CID_154699675 | ||
| 0.497 | 0.033 | 0.497 | 5 Hydroxytryptamine release inhibitor | 0.382 0.09 CID_154699675 | ||
| 0.468 | 0.005 | 0.468 | Sodium/bile acid cotransporter inhibitor | 0.376 0.026 CID_154699675 | ||
| 0.462 | 0.017 | 0.462 | Superoxide dismutase inhibitor | |||
| 0.423 | 0.004 | 0.423 | Alcohol dehydrogenase inhibitor | 0.186 0.014 CID_154699675 | ||
| 0.461 | 0.045 | 0.473 | Histamine release inhibitor | 0.473 0.039 CID_154699675 | CID_154699675 | |
| 0.43 | 0.015 | 0.43 | Calcium channel activator | 0.246 0.152 CID_154699675 | ||
| 0.422 | 0.007 | 0.422 | Protein-tyrosine phosphatase inhibitor | 0.334 0.014 CID_154699675 | ||
| 0.4 | 0.004 | 0.4 | Succinate dehydrogenase inhibitor | 0.147 0.119 CID_154699675 | ||
| 0.398 | 0.004 | 0.398 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.365 0.004 CID_154699675 | ||
| 0.397 | 0.004 | 0.397 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.449 | 0.062 | 0.449 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.445 | 0.058 | 0.659 | Antibacterial | 0.659 0.012 CID_154699675 | CID_154699675 | |
| 0.389 | 0.006 | 0.463 | UDP-glucose 4-epimerase inhibitor | 0.463 0.004 CID_154699675 | CID_154699675 | |
| 0.387 | 0.005 | 0.387 | NMDA receptor antagonist | |||
| 0.394 | 0.015 | 0.394 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.385 | 0.014 | 0.385 | MAP kinase kinase 2 inhibitor | |||
| 0.375 | 0.004 | 0.375 | Aminoacyl-tRNA synthetase inhibitor | 0.19 0.012 CID_154699675 | ||
| 0.403 | 0.034 | 0.622 | Vasodilator, coronary | 0.622 0.007 CID_154699675 | CID_154699675 | |
| 0.389 | 0.026 | 0.389 | Amyloid beta aggregation inhibitor | 0.348 0.035 CID_154699675 | ||
| 0.38 | 0.025 | 0.38 | Pyruvate kinase inhibitor | 0.138 0.126 CID_154699675 | ||
| 0.355 | 0.004 | 0.355 | Mannose-6-phosphate isomerase inhibitor | 0.348 0.004 CID_154699675 | ||
| 0.354 | 0.005 | 0.354 | Carbonic anhydrase XV inhibitor | |||
| 0.369 | 0.026 | 0.498 | DNA synthesis inhibitor | 0.498 0.013 CID_154699675 | CID_154699675 | |
| 0.346 | 0.003 | 0.346 | Electrolyte absorption antagonist | |||
| 0.345 | 0.004 | 0.345 | Sigma 1 receptor antagonist | |||
| 0.343 | 0.002 | 0.343 | Glutamate (mGluR4) antagonist | |||
| 0.341 | 0.002 | 0.341 | Glutamate (mGluR group III) antagonist | |||
| 0.341 | 0.004 | 0.341 | NMDA 2 receptor antagonist | |||
| 0.336 | 0.001 | 0.336 | NMDA 2D receptor antagonist | 0.1 0.004 CID_154699675 | ||
| 0.353 | 0.028 | 0.353 | Peroxidase inhibitor | |||
| 0.327 | 0.003 | 0.327 | NMDA receptor subunit 3A antagonist | |||
| 0.324 | 0.003 | 0.324 | Biliverdin reductase inhibitor | 0.116 0.014 CID_154699675 | ||
| 0.327 | 0.006 | 0.327 | MAP kinase kinase inhibitor | |||
| 0.359 | 0.038 | 0.476 | DNA damaging | 0.476 0.016 CID_154699675 | CID_154699675 | |
| 0.375 | 0.056 | 0.747 | Antithrombotic | 0.747 0.006 CID_154699675 | CID_154699675 | |
| 0.35 | 0.034 | 0.35 | Transcription factor STAT inhibitor | 0.188 0.156 CID_154699675 | ||
| 0.382 | 0.068 | 0.77 | Transcription factor NF kappa B inhibitor | 0.77 0.015 CID_154699675 | CID_154699675 | |
| 0.382 | 0.069 | 0.382 | GABA C receptor rho-3 antagonist | |||
| 0.317 | 0.005 | 0.456 | ATPase inhibitor | 0.456 0.003 CID_154699675 | CID_154699675 | |
| 0.312 | 0.002 | 0.312 | Glutamate (mGluR3) antagonist | 0.035 0.028 CID_154699675 | ||
| 0.311 | 0.006 | 0.311 | Adenylate kinase inhibitor | 0.187 0.017 CID_154699675 | ||
| 0.313 | 0.015 | 0.436 | Protein kinase stimulant | 0.436 0.006 CID_154699675 | CID_154699675 | |
| 0.307 | 0.009 | 0.307 | Glutamate receptor antagonist | |||
| 0.338 | 0.042 | 0.558 | Antiamyloidogenic | 0.558 0.011 CID_154699675 | CID_154699675 | |
| 0.3 | 0.004 | 0.3 | NMDA receptor subunit 3B antagonist | |||
| 0.297 | 0.003 | 0.297 | Prostaglandin F2 alpha antagonist | 0.106 0.009 CID_154699675 | ||
| 0.302 | 0.01 | 0.302 | Protein-tyrosine phosphatase 1B inhibitor | 0.292 0.011 CID_154699675 | ||
| 0.397 | 0.115 | 0.735 | Apoptosis agonist | 0.735 0.025 CID_154699675 | CID_154699675 | |
| 0.338 | 0.056 | 0.56 | Spasmolytic | 0.56 0.017 CID_154699675 | CID_154699675 | |
| 0.302 | 0.025 | 0.302 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.28 | 0.004 | 0.28 | NMDA 2A receptor antagonist | |||
| 0.28 | 0.005 | 0.28 | Uric acid excretion stimulant | 0.208 0.012 CID_154699675 | ||
| 0.277 | 0.002 | 0.277 | Aconitate hydratase inhibitor | |||
| 0.278 | 0.003 | 0.278 | DOPA decarboxylase inhibitor | 0.096 0.083 CID_154699675 | ||
| 0.276 | 0.003 | 0.276 | Kainate receptor antagonist | |||
| 0.372 | 0.101 | 0.372 | Calcium channel L-type activator | |||
| 0.274 | 0.002 | 0.274 | D-Ala-D-Ala ligase inhibitor | 0.085 0.054 CID_154699675 | ||
| 0.275 | 0.005 | 0.275 | Creatine kinase inhibitor | |||
| 0.283 | 0.013 | 0.283 | Protein kinase (CK2) alpha inhibitor | |||
| 0.273 | 0.016 | 0.273 | Adenylate cyclase inhibitor | 0.196 0.026 CID_154699675 | ||
| 0.26 | 0.003 | 0.26 | Kainate receptor 5 antagonist | |||
| 0.27 | 0.014 | 0.271 | Hexokinase inhibitor | 0.271 0.014 CID_154699675 | CID_154699675 | |
| 0.259 | 0.003 | 0.259 | AMPA 4 receptor antagonist | |||
| 0.264 | 0.01 | 0.264 | Protein kinase (CK2) inhibitor | |||
| 0.256 | 0.005 | 0.256 | MAP kinase kinase 5 inhibitor | 0.154 0.136 CID_154699675 | ||
| 0.261 | 0.012 | 0.261 | Cathepsin H inhibitor | 0.104 0.1 CID_154699675 | ||
| 0.253 | 0.006 | 0.319 | Photosensitizer | 0.319 0.004 CID_154699675 | CID_154699675 | |
| 0.249 | 0.002 | 0.249 | Kainate receptor 1 antagonist | |||
| 0.249 | 0.008 | 0.425 | NADH dehydrogenase inhibitor | 0.425 0.004 CID_154699675 | CID_154699675 | |
| 0.314 | 0.077 | 0.625 | Apoptosis antagonist | 0.625 0.007 CID_154699675 | CID_154699675 | |
| 0.239 | 0.005 | 0.239 | Glutamate decarboxylase inhibitor | |||
| 0.223 | 0.004 | 0.223 | Glycine receptor agonist | 0.151 0.007 CID_154699675 | ||
| 0.224 | 0.004 | 0.224 | NMDA receptor agonist | |||
| 0.23 | 0.01 | 0.23 | Histidine decarboxylase inhibitor | |||
| 0.219 | 0.004 | 0.219 | Purinergic P2X2 antagonist | 0.134 0.015 CID_154699675 | ||
| 0.216 | 0.004 | 0.216 | MAP kinase kinase 1 inhibitor | |||
| 0.214 | 0.005 | 0.214 | NMDA 2C receptor antagonist | |||
| 0.241 | 0.032 | 0.241 | Diuretic | 0.198 0.045 CID_154699675 | ||
| 0.238 | 0.031 | 0.238 | Histone acetyltransferase inhibitor | |||
| 0.277 | 0.074 | 0.277 | Insulysin inhibitor | |||
| 0.206 | 0.005 | 0.206 | Acyl-CoA dehydrogenase inhibitor | 0.066 0.029 CID_154699675 | ||
| 0.214 | 0.018 | 0.214 | Aminopeptidase B inhibitor | |||
| 0.202 | 0.009 | 0.202 | Caspase 3 inhibitor | |||
| 0.205 | 0.014 | 0.205 | MAP3K9 inhibitor | |||
| 0.245 | 0.054 | 0.245 | Death-associated protein kinase 3 inhibitor | |||
| 0.193 | 0.004 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 CID_154699675 | ||
| 0.19 | 0.004 | 0.19 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.129 0.01 CID_154699675 | ||
| 0.225 | 0.043 | 0.225 | Lipocortins synthesis antagonist | |||
| 0.248 | 0.066 | 0.248 | Calpain inhibitor | |||
| 0.249 | 0.07 | 0.842 | Angiogenesis stimulant | 0.842 0.003 CID_154699675 | CID_154699675 | |
| 0.192 | 0.014 | 0.192 | Carbonic anhydrase VI inhibitor | 0.088 0.048 CID_154699675 | ||
| 0.235 | 0.057 | 0.299 | DNA methylase inhibitor | 0.299 0.028 CID_154699675 | CID_154699675 | |
| 0.184 | 0.008 | 0.184 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.18 | 0.009 | 0.18 | Argininosuccinate synthase inhibitor | 0.057 0.04 CID_154699675 | ||
| 0.173 | 0.004 | 0.173 | NMDA receptor glycine site agonist | |||
| 0.185 | 0.018 | 0.185 | Catalase inhibitor | |||
| 0.247 | 0.081 | 0.334 | Interleukin agonist | 0.334 0.034 CID_154699675 | CID_154699675 | |
| 0.191 | 0.025 | 0.191 | Farnesoid X receptor antagonist | |||
| 0.175 | 0.013 | 0.175 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.166 | 0.005 | 0.166 | ATPase (Vacuolar H+) inhibitor | 0.161 0.005 CID_154699675 | ||
| 0.165 | 0.004 | 0.165 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.169 | 0.01 | 0.169 | Aminopeptidase I inhibitor | |||
| 0.169 | 0.01 | 0.169 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.163 | 0.004 | 0.163 | TRPM8 blocker | |||
| 0.244 | 0.087 | 0.244 | Gastrin inhibitor | |||
| 0.17 | 0.013 | 0.17 | Transcription factor STAT6 inhibitor | |||
| 0.171 | 0.014 | 0.222 | Phosphofructokinase-1 inhibitor | 0.222 0.009 CID_154699675 | CID_154699675 | |
| 0.161 | 0.005 | 0.161 | Dopamine transporter inhibitor | |||
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | |||
| 0.156 | 0.003 | 0.156 | NMDA receptor glycine site antagonist | |||
| 0.155 | 0.003 | 0.155 | Glutamate (mGluR7) antagonist | |||
| 0.17 | 0.018 | 0.298 | DNA repair enzyme inhibitor | 0.298 0.004 CID_154699675 | CID_154699675 | |
| 0.158 | 0.006 | 0.214 | Glycine receptor antagonist | 0.214 0.003 CID_154699675 | CID_154699675 | |
| 0.156 | 0.005 | 0.156 | Plasminogen activator inhibitor antagonist | |||
| 0.18 | 0.03 | 0.18 | Interleukin 4 antagonist | 0.177 0.031 CID_154699675 | ||
| 0.161 | 0.011 | 0.161 | Somatostatin 1 agonist | 0.075 0.057 CID_154699675 | ||
| 0.25 | 0.1 | 0.304 | Hypoxia-inducible factor 1 alpha inhibitor | 0.304 0.064 CID_154699675 | CID_154699675 | |
| 0.226 | 0.077 | 0.304 | Cyclic AMP phosphodiesterase inhibitor | 0.304 0.04 CID_154699675 | CID_154699675 | |
| 0.167 | 0.019 | 0.167 | Carbonic anhydrase XIII inhibitor | 0.083 0.047 CID_154699675 | ||
| 0.211 | 0.064 | 0.211 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.151 | 0.004 | 0.151 | Thromboxane synthase inhibitor | |||
| 0.189 | 0.044 | 0.189 | Arachidonic acid antagonist | |||
| 0.155 | 0.011 | 0.155 | Interleukin 12 antagonist | 0.134 0.019 CID_154699675 | ||
| 0.146 | 0.003 | 0.146 | Retinoic acid alpha receptor agonist | 0.04 0.026 CID_154699675 | ||
| 0.147 | 0.004 | 0.147 | Fumarate hydratase inhibitor | 0.046 0.015 CID_154699675 | ||
| 0.147 | 0.005 | 0.147 | Thromboxane antagonist | 0.053 0.039 CID_154699675 | ||
| 0.152 | 0.011 | 0.152 | Sigma receptor antagonist | |||
| 0.164 | 0.023 | 0.164 | GABA C receptor antagonist | |||
| 0.143 | 0.003 | 0.143 | Retinoid X alpha receptor agonist | |||
| 0.184 | 0.047 | 0.184 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.14 | 0.003 | 0.14 | AICAR transformylase inhibitor | 0.056 0.016 CID_154699675 | ||
| 0.139 | 0.003 | 0.139 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.139 | 0.004 | 0.139 | Kainate receptor 2 antagonist | |||
| 0.149 | 0.014 | 0.149 | Histamine N-methyltransferase inhibitor | |||
| 0.137 | 0.003 | 0.137 | MDM2 inhibitor | |||
| 0.173 | 0.04 | 0.173 | MAP kinase 3 inhibitor | |||
| 0.163 | 0.03 | 0.22 | Xanthine oxidase inhibitor | 0.22 0.016 CID_154699675 | CID_154699675 | |
| 0.148 | 0.015 | 0.148 | Adrenaline agonist | |||
| 0.141 | 0.008 | 0.141 | Xanthine dehydrogenase inhibitor | 0.066 0.034 CID_154699675 | ||
| 0.136 | 0.004 | 0.136 | Thromboxane A2 antagonist | 0.056 0.031 CID_154699675 | ||
| 0.139 | 0.008 | 0.139 | Purinergic P2X1 antagonist | 0.064 0.038 CID_154699675 | ||
| 0.159 | 0.028 | 0.176 | Mucolytic | 0.176 0.02 CID_154699675 | CID_154699675 | |
| 0.139 | 0.011 | 0.139 | Prostaglandin EP2 antagonist | |||
| 0.143 | 0.015 | 0.143 | Cyclin B3 inhibitor | |||
| 0.137 | 0.01 | 0.137 | Bile acid receptor antagonist | 0.092 0.069 CID_154699675 | ||
| 0.14 | 0.014 | 0.14 | Adenosine A3 receptor antagonist | 0.098 0.027 CID_154699675 | ||
| 0.182 | 0.059 | 0.182 | Phospholipase C inhibitor | |||
| 0.137 | 0.013 | 0.137 | Histamine H2 receptor antagonist | |||
| 0.14 | 0.018 | 0.155 | Carbonic anhydrase inhibitor | 0.155 0.015 CID_154699675 | CID_154699675 | |
| 0.13 | 0.009 | 0.242 | Phosphorylase inhibitor | 0.242 0.004 CID_154699675 | CID_154699675 | |
| 0.124 | 0.004 | 0.124 | Dihydroorotate oxidase inhibitor | |||
| 0.128 | 0.008 | 0.128 | Beta 3 adrenoreceptor antagonist | |||
| 0.169 | 0.051 | 0.169 | GABA C receptor rho-2 antagonist | |||
| 0.194 | 0.076 | 0.406 | Non-steroidal antiinflammatory agent | 0.406 0.013 CID_154699675 | CID_154699675 | |
| 0.172 | 0.054 | 0.424 | Amylase inhibitor | 0.424 0.008 CID_154699675 | CID_154699675 | |
| 0.127 | 0.011 | 0.127 | Prostaglandin E2 antagonist | |||
| 0.129 | 0.013 | 0.129 | Dopamine uptake inhibitor | |||
| 0.121 | 0.005 | 0.121 | Glutamate (mGluR6) antagonist | |||
| 0.137 | 0.021 | 0.149 | Thioredoxin inhibitor | 0.149 0.017 CID_154699675 | CID_154699675 | |
| 0.161 | 0.045 | 0.161 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.127 | 0.012 | 0.127 | Ornithine carbamoyltransferase inhibitor | |||
| 0.119 | 0.004 | 0.119 | AMPA 3 receptor antagonist | |||
| 0.118 | 0.004 | 0.118 | Nicotinic acid receptor agonist | |||
| 0.169 | 0.056 | 0.169 | CDC-like kinase 1 inhibitor | |||
| 0.131 | 0.019 | 0.131 | Ornithine decarboxylase inhibitor | |||
| 0.222 | 0.109 | 0.222 | Transcription factor STAT3 inhibitor | |||
| 0.116 | 0.004 | 0.116 | Retinoic acid receptor agonist | |||
| 0.119 | 0.007 | 0.119 | Phosphodiesterase 1C inhibitor | |||
| 0.116 | 0.006 | 0.116 | Phosphoglycerate kinase inhibitor | 0.056 0.012 CID_154699675 | ||
| 0.141 | 0.032 | 0.141 | Carbonic anhydrase III inhibitor | |||
| 0.208 | 0.098 | 0.529 | Vasodilator | 0.529 0.01 CID_154699675 | CID_154699675 | |
| 0.111 | 0.002 | 0.111 | Nicotinic acid receptor 2 antagonist | |||
| 0.11 | 0.002 | 0.11 | Thyroid hormone alpha agonist | 0.022 0.005 CID_154699675 | ||
| 0.134 | 0.027 | 0.134 | Androgen antagonist | |||
| 0.238 | 0.131 | 0.238 | Thyroid hormone antagonist | |||
| 0.11 | 0.004 | 0.11 | Retinoid X receptor agonist | |||
| 0.161 | 0.055 | 0.161 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.15 | 0.045 | 0.15 | Heat shock protein 70 antagonist | |||
| 0.178 | 0.074 | 0.178 | LIM domain kinase 1 inhibitor | |||
| 0.135 | 0.032 | 0.135 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.13 | 0.028 | 0.13 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.164 | 0.062 | 0.223 | Interferon gamma antagonist | 0.223 0.034 CID_154699675 | CID_154699675 | |
| 0.105 | 0.004 | 0.105 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.135 | 0.033 | 0.539 | Beta glucuronidase inhibitor | 0.539 0.003 CID_154699675 | CID_154699675 | |
| 0.116 | 0.015 | 0.116 | Carbonic anhydrase I inhibitor | 0.087 0.022 CID_154699675 | ||
| 0.139 | 0.04 | 0.347 | Expectorant | 0.347 0.006 CID_154699675 | CID_154699675 | |
| 0.109 | 0.01 | 0.109 | AMPA receptor antagonist | |||
| 0.148 | 0.05 | 0.247 | Cyclooxygenase 3 inhibitor | 0.247 0.009 CID_154699675 | CID_154699675 | |
| 0.102 | 0.005 | 0.102 | AMPA 1 receptor antagonist | |||
| 0.1 | 0.004 | 0.1 | Membrane dipeptidase inhibitor | |||
| 0.102 | 0.005 | 0.102 | Nicotinic acid receptor 2 agonist | |||
| 0.107 | 0.014 | 0.107 | Beta adrenoreceptor antagonist | |||
| 0.113 | 0.021 | 0.113 | Adenosine A1 receptor antagonist | 0.066 0.035 CID_154699675 | ||
| 0.095 | 0.003 | 0.095 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.097 | 0.006 | 0.097 | Leukotriene A4 hydrolase inhibitor | |||
| 0.096 | 0.005 | 0.096 | RNA-directed RNA polymerase inhibitor | |||
| 0.139 | 0.049 | 0.248 | Beta amyloid protein antagonist | 0.248 0.009 CID_154699675 | CID_154699675 | |
| 0.108 | 0.017 | 0.108 | Carbonic anhydrase II inhibitor | 0.092 0.021 CID_154699675 | ||
| 0.276 | 0.185 | 0.748 | Cyclophilin D inhibitor | 0.748 0.01 CID_154699675 | CID_154699675 | |
| 0.153 | 0.063 | 0.264 | Cell wall synthesis inhibitor | 0.264 0.014 CID_154699675 | CID_154699675 | |
| 0.146 | 0.057 | 0.146 | NADPH oxidase inhibitor | |||
| 0.094 | 0.005 | 0.094 | Urate transporter 1 inhibitor | |||
| 0.112 | 0.024 | 0.112 | Myeloperoxidase inhibitor | |||
| 0.091 | 0.005 | 0.091 | Adenine nucleotide translocase inhibitor | 0.085 0.007 CID_154699675 | ||
| 0.089 | 0.003 | 0.089 | Retinoic acid beta receptor agonist | |||
| 0.138 | 0.053 | 0.14 | Vanilloid 1 agonist | 0.14 0.05 CID_154699675 | CID_154699675 | |
| 0.301 | 0.215 | 0.833 | Antiinflammatory | 0.833 0.011 CID_154699675 | CID_154699675 | |
| 0.096 | 0.011 | 0.096 | Beta 1 adrenoreceptor antagonist | |||
| 0.107 | 0.023 | 0.107 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.111 | 0.028 | 0.111 | Glutathione S-transferase inhibitor | |||
| 0.099 | 0.016 | 0.099 | Carbonic anhydrase VB inhibitor | |||
| 0.099 | 0.016 | 0.099 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.193 | 0.11 | 0.193 | RNA-directed DNA polymerase inhibitor | |||
| 0.121 | 0.039 | 0.121 | Anabolic | |||
| 0.085 | 0.003 | 0.085 | Kainate receptor agonist | |||
| 0.095 | 0.014 | 0.095 | Autotaxin inhibitor | |||
| 0.131 | 0.05 | 0.235 | Microtubule formation inhibitor | 0.235 0.013 CID_154699675 | CID_154699675 | |
| 0.099 | 0.019 | 0.099 | Carbonic anhydrase stimulant | |||
| 0.104 | 0.024 | 0.104 | Caspase 7 inhibitor | |||
| 0.085 | 0.006 | 0.085 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.126 | 0.048 | 0.126 | Chelator | |||
| 0.132 | 0.055 | 0.132 | Cholesterol synthesis inhibitor | |||
| 0.133 | 0.058 | 0.133 | Anesthetic local | |||
| 0.106 | 0.031 | 0.106 | Cathepsin G inhibitor | |||
| 0.093 | 0.018 | 0.135 | Neuraminidase (influenza) inhibitor | 0.135 0.009 CID_154699675 | CID_154699675 | |
| 0.169 | 0.095 | 0.213 | Anesthetic general | 0.213 0.067 CID_154699675 | CID_154699675 | |
| 0.161 | 0.087 | 0.161 | Dual specificity phosphatase 3 inhibitor | |||
| 0.084 | 0.01 | 0.084 | Beta 2 adrenoreceptor antagonist | |||
| 0.094 | 0.02 | 0.094 | Adrenaline uptake inhibitor | |||
| 0.08 | 0.008 | 0.08 | Somatostatin 5 antagonist | |||
| 0.078 | 0.006 | 0.078 | HCV NS5B polymerase inhibitor | |||
| 0.148 | 0.076 | 0.148 | Phospholipase A2 inhibitor | |||
| 0.183 | 0.112 | 0.622 | Free radical scavenger | 0.622 0.007 CID_154699675 | CID_154699675 | |
| 0.107 | 0.037 | 0.107 | Phosphodiesterase I inhibitor | |||
| 0.088 | 0.018 | 0.088 | Phosphodiesterase 1B inhibitor | |||
| 0.071 | 0.001 | 0.071 | Complement factor 1r inhibitor | 0.045 0.004 CID_154699675 | ||
| 0.076 | 0.007 | 0.076 | GABA B receptor antagonist | |||
| 0.077 | 0.008 | 0.077 | Thymidylate synthase inhibitor | |||
| 0.073 | 0.005 | 0.073 | Kainate receptor 4 antagonist | |||
| 0.093 | 0.025 | 0.093 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.075 | 0.007 | 0.075 | AMPA 2 receptor antagonist | |||
| 0.101 | 0.033 | 0.101 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.071 | 0.004 | 0.071 | Uridine phosphorylase inhibitor | 0.064 0.005 CID_154699675 | ||
| 0.075 | 0.009 | 0.183 | Heparanase inhibitor | 0.183 0.002 CID_154699675 | CID_154699675 | |
| 0.123 | 0.056 | 0.123 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.137 | 0.072 | 0.137 | Neurotrophic factor | |||
| 0.076 | 0.011 | 0.097 | Squalene epoxidase inhibitor | 0.097 0.005 CID_154699675 | CID_154699675 | |
| 0.089 | 0.025 | 0.089 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.184 | 0.12 | 0.184 | Nitric-oxide synthase stimulant | 0.184 0.119 CID_154699675 | ||
| 0.068 | 0.005 | 0.068 | Glutamate (mGluR8) agonist | |||
| 0.067 | 0.004 | 0.067 | Retinoid X gamma receptor agonist | |||
| 0.068 | 0.006 | 0.068 | Guanylate cyclase inhibitor | 0.056 0.016 CID_154699675 | ||
| 0.066 | 0.004 | 0.066 | Retinoid X beta receptor agonist | |||
| 0.078 | 0.017 | 0.078 | Sphingosine kinase 2 inhibitor | |||
| 0.188 | 0.127 | 0.52 | Immunostimulant | 0.52 0.026 CID_154699675 | CID_154699675 | |
| 0.083 | 0.023 | 0.083 | CDK4/cyclin D1 inhibitor | |||
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | |||
| 0.09 | 0.03 | 0.09 | Carbonic anhydrase VA inhibitor | |||
| 0.091 | 0.031 | 0.419 | Selectin antagonist | 0.419 0.003 CID_154699675 | CID_154699675 | |
| 0.083 | 0.024 | 0.097 | Neuraminidase inhibitor | 0.097 0.016 CID_154699675 | CID_154699675 | |
| 0.073 | 0.016 | 0.073 | Epithelial sodium channel blocker | |||
| 0.103 | 0.047 | 0.103 | Protein kinase C zeta inhibitor | |||
| 0.096 | 0.039 | 0.096 | Chymotrypsin inhibitor | |||
| 0.09 | 0.034 | 0.09 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.065 | 0.008 | 0.065 | GABA uptake inhibitor | |||
| 0.092 | 0.036 | 0.151 | Interferon agonist | 0.151 0.01 CID_154699675 | CID_154699675 | |
| 0.075 | 0.019 | 0.075 | Phosphodiesterase 1A inhibitor | |||
| 0.07 | 0.014 | 0.07 | Carbonic anhydrase IV inhibitor | |||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase V inhibitor | |||
| 0.093 | 0.039 | 0.093 | Macrophage migration inhibitory factor inhibitor | |||
| 0.067 | 0.014 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.1 0.005 CID_154699675 | CID_154699675 | |
| 0.06 | 0.006 | 0.06 | Angiotensin AT1 receptor antagonist | |||
| 0.072 | 0.02 | 0.072 | Cyclin B2 inhibitor | |||
| 0.066 | 0.013 | 0.066 | Dihydroorotase inhibitor | |||
| 0.059 | 0.006 | 0.059 | Heme oxygenase inhibitor | |||
| 0.057 | 0.005 | 0.057 | Purinergic P2Y14 antagonist | |||
| 0.062 | 0.01 | 0.062 | Glutamate (mGluR group II) antagonist | |||
| 0.148 | 0.096 | 0.148 | Dual specificity phosphatase inhibitor | |||
| 0.07 | 0.019 | 0.07 | Beta 2 adrenoreceptor agonist | |||
| 0.06 | 0.008 | 0.06 | Beta adrenoreceptor agonist | |||
| 0.065 | 0.014 | 0.159 | Mannosidase inhibitor | 0.159 0.004 CID_154699675 | CID_154699675 | |
| 0.06 | 0.009 | 0.06 | p53 inhibitor | |||
| 0.063 | 0.013 | 0.063 | Thymidine kinase inhibitor | 0.056 0.015 CID_154699675 | ||
| 0.065 | 0.015 | 0.065 | Potassium channel (Inward rectifier) activator | |||
| 0.114 | 0.065 | 0.114 | TRPA1 agonist | |||
| 0.064 | 0.015 | 0.064 | 5-Alpha-reductase inhibitor | |||
| 0.054 | 0.006 | 0.054 | Protein kinase (CK2) beta inhibitor | |||
| 0.076 | 0.028 | 0.12 | Interferon inducer | 0.12 0.007 CID_154699675 | CID_154699675 | |
| 0.052 | 0.004 | 0.052 | Thyroid hormone alpha antagonist | |||
| 0.084 | 0.036 | 0.084 | MAP kinase kinase 7 inhibitor | |||
| 0.062 | 0.014 | 0.062 | Potassium channel (ATP-sensitive) activator | |||
| 0.084 | 0.037 | 0.084 | Prostaglandin-E synthase inhibitor | |||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | |||
| 0.093 | 0.046 | 0.093 | Histamine H1 receptor antagonist | |||
| 0.064 | 0.018 | 0.064 | Adenosine deaminase inhibitor | 0.052 0.028 CID_154699675 | ||
| 0.075 | 0.029 | 0.075 | TRPA1 antagonist | |||
| 0.066 | 0.02 | 0.066 | Pregnane X receptor antagonist | |||
| 0.074 | 0.028 | 0.101 | Carbonic anhydrase XII inhibitor | 0.101 0.02 CID_154699675 | CID_154699675 | |
| 0.075 | 0.029 | 0.084 | Carbonic anhydrase IX inhibitor | 0.084 0.025 CID_154699675 | CID_154699675 | |
| 0.064 | 0.019 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.051 | 0.006 | 0.051 | Angiotensin II receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Beta 1 adrenoreceptor agonist | |||
| 0.049 | 0.004 | 0.049 | Kainate receptor 3 antagonist | |||
| 0.065 | 0.021 | 0.14 | Alpha-mannosidase inhibitor | 0.14 0.004 CID_154699675 | CID_154699675 | |
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | |||
| 0.06 | 0.015 | 0.06 | Purinergic P2X4 antagonist | |||
| 0.064 | 0.02 | 0.064 | Prolyl endopeptidase inhibitor | 0.053 0.033 CID_154699675 | ||
| 0.162 | 0.118 | 0.162 | Insulin sensitizer | |||
| 0.048 | 0.005 | 0.048 | Glutamate (mGluR3) agonist | |||
| 0.068 | 0.025 | 0.068 | Urokinase inhibitor | |||
| 0.05 | 0.008 | 0.05 | ATP citrate lysase inhibitor | |||
| 0.126 | 0.083 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.088 | 0.046 | 0.088 | Estrogen-related receptor beta agonist | |||
| 0.069 | 0.027 | 0.069 | Prostaglandin antagonist | |||
| 0.122 | 0.081 | 0.122 | Nav1.2 sodium channel blocker | |||
| 0.048 | 0.008 | 0.048 | Retinoid X alpha receptor antagonist | |||
| 0.052 | 0.012 | 0.052 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.056 | 0.016 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.064 0.01 CID_154699675 | CID_154699675 | |
| 0.044 | 0.004 | 0.044 | Retinoic acid alpha receptor antagonist | |||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | |||
| 0.043 | 0.004 | 0.043 | Retinoic acid receptor antagonist | |||
| 0.055 | 0.018 | 0.055 | Benzodiazepine antagonist | |||
| 0.057 | 0.021 | 0.057 | Factor III inhibitor | |||
| 0.159 | 0.123 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.131 | 0.095 | 0.131 | Acetylcholine M1 receptor antagonist | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.039 | 0.004 | 0.039 | Retinoic acid gamma receptor agonist | |||
| 0.064 | 0.03 | 0.088 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 CID_154699675 | CID_154699675 | |
| 0.043 | 0.01 | 0.043 | Prostaglandin EP4 antagonist | |||
| 0.045 | 0.011 | 0.045 | Glutamate (mGluR8) antagonist | |||
| 0.059 | 0.025 | 0.082 | Carbonic anhydrase XIV inhibitor | 0.082 0.016 CID_154699675 | CID_154699675 | |
| 0.05 | 0.018 | 0.05 | Dihydrofolate reductase inhibitor | |||
| 0.06 | 0.028 | 0.06 | Leukotriene C antagonist | |||
| 0.091 | 0.059 | 0.091 | Potassium channel activator | |||
| 0.057 | 0.025 | 0.057 | CD45 antagonist | |||
| 0.071 | 0.04 | 0.071 | Potassium channel (ATP-sensitive) blocker | |||
| 0.064 | 0.033 | 0.064 | Sphingosine kinase inhibitor | |||
| 0.037 | 0.007 | 0.037 | Prostaglandin H2 antagonist | |||
| 0.036 | 0.006 | 0.036 | Retinoid X gamma receptor antagonist | |||
| 0.038 | 0.007 | 0.038 | Thymidine phosphorylase inhibitor | 0.025 0.021 CID_154699675 | ||
| 0.034 | 0.004 | 0.034 | CXC chemokine 5 receptor antagonist | |||
| 0.032 | 0.003 | 0.032 | Carbonic anhydrase XI inhibitor | |||
| 0.062 | 0.032 | 0.062 | Ryanodine receptor antagonist | |||
| 0.04 | 0.011 | 0.04 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.046 | 0.017 | 0.046 | Farnesoid X receptor agonist | |||
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.033 0.008 CID_154699675 | ||
| 0.128 | 0.1 | 0.128 | Thiol protease inhibitor | |||
| 0.06 | 0.032 | 0.06 | Cyclin B inhibitor | |||
| 0.058 | 0.031 | 0.058 | Leukotriene B4 antagonist | 0.053 0.039 CID_154699675 | ||
| 0.077 | 0.05 | 0.077 | Acetylcholine M4 receptor antagonist | |||
| 0.03 | 0.004 | 0.03 | Retinoic acid beta receptor antagonist | |||
| 0.03 | 0.004 | 0.03 | Retinoid X beta receptor antagonist | |||
| 0.072 | 0.046 | 0.072 | HIV-1 integrase inhibitor | |||
| 0.035 | 0.009 | 0.035 | Thyroid hormone agonist | |||
| 0.034 | 0.008 | 0.034 | 5-Alpha-reductase 1 inhibitor | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.04 | 0.015 | 0.04 | Dipeptidyl peptidase II inhibitor | |||
| 0.048 | 0.023 | 0.048 | Growth hormone release inhibitor | |||
| 0.129 | 0.104 | 0.129 | Adenylate cyclase stimulant | |||
| 0.03 | 0.005 | 0.03 | Adenosine A3 receptor agonist | 0.022 0.008 CID_154699675 | ||
| 0.029 | 0.004 | 0.029 | Complement factor 1 inhibitor | |||
| 0.133 | 0.109 | 0.192 | Melanin inhibitor | 0.192 0.044 CID_154699675 | CID_154699675 | |
| 0.032 | 0.008 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 CID_154699675 | CID_154699675 | |
| 0.173 | 0.149 | 0.173 | 5 Hydroxytryptamine release stimulant | |||
| 0.054 | 0.031 | 0.054 | Carbonic anhydrase II stimulant | |||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.037 | 0.015 | 0.037 | Prostaglandin agonist | |||
| 0.058 | 0.035 | 0.058 | 5 Hydroxytryptamine 7 agonist | |||
| 0.026 | 0.004 | 0.026 | Retinoic acid receptor gamma antagonist | |||
| 0.06 | 0.039 | 0.06 | Glutamate (mGluR1) antagonist | |||
| 0.11 | 0.089 | 0.11 | Toll-Like receptor 2 antagonist | |||
| 0.141 | 0.12 | 0.568 | Hepatoprotectant | 0.568 0.005 CID_154699675 | CID_154699675 | |
| 0.043 | 0.023 | 0.043 | Dihydropteroate synthase inhibitor | |||
| 0.035 | 0.015 | 0.035 | Glutamate (mGluR2) antagonist | |||
| 0.114 | 0.094 | 0.114 | Alkaline phosphatase inhibitor | |||
| 0.025 | 0.004 | 0.025 | Beta 3 adrenoreceptor agonist | |||
| 0.06 | 0.041 | 0.06 | Bcl-xL inhibitor | |||
| 0.047 | 0.028 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.032 | 0.014 | 0.032 | MAP3K8 inhibitor | |||
| 0.024 | 0.006 | 0.024 | Nicotinic acid receptor 1 antagonist | |||
| 0.098 | 0.08 | 0.098 | Protein kinase C gamma inhibitor | |||
| 0.075 | 0.058 | 0.075 | Glutamate receptor agonist | |||
| 0.087 | 0.07 | 0.107 | Glutamate release inhibitor | 0.107 0.033 CID_154699675 | CID_154699675 | |
| 0.023 | 0.006 | 0.023 | Carbonic anhydrase X inhibitor | |||
| 0.023 | 0.006 | 0.023 | Carbonic anhydrase VIII inhibitor | |||
| 0.028 | 0.012 | 0.028 | Prostaglandin E2 agonist | |||
| 0.022 | 0.005 | 0.022 | Egl nine homolog 1 inhibitor | |||
| 0.024 | 0.008 | 0.024 | Prostaglandin EP4 agonist | |||
| 0.046 | 0.03 | 0.046 | Oleamide hydrolase inhibitor | |||
| 0.049 | 0.033 | 0.049 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | |||
| 0.03 | 0.015 | 0.03 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.039 | 0.023 | 0.04 | Arginase inhibitor | 0.04 0.022 CID_154699675 | CID_154699675 | |
| 0.021 | 0.007 | 0.021 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.031 | 0.016 | 0.031 | Sigma 2 receptor antagonist | |||
| 0.061 | 0.046 | 0.061 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.031 | 0.016 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.026 | 0.011 | 0.026 | Prostaglandin EP1 antagonist | |||
| 0.033 | 0.019 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.109 | 0.095 | 0.109 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.059 | 0.045 | 0.059 | Adenosine A2a receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Caspase 8 inhibitor | |||
| 0.047 | 0.034 | 0.047 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.02 | 0.006 | 0.02 | Angiotensin AT1B receptor antagonist | |||
| 0.039 | 0.026 | 0.039 | Leukotriene C4 antagonist | |||
| 0.057 | 0.043 | 0.057 | CDK4/cyclin D inhibitor | |||
| 0.038 | 0.026 | 0.038 | Integrin alpha1beta1 antagonist | |||
| 0.141 | 0.128 | 0.141 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.015 | 0.003 | 0.015 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.122 | 0.11 | 0.298 | Hemostatic | 0.298 0.016 CID_154699675 | CID_154699675 | |
| 0.045 | 0.033 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.07 | 0.059 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.134 | 0.122 | 0.134 | Tumour necrosis factor antagonist | |||
| 0.033 | 0.021 | 0.033 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.025 | 0.015 | 0.025 | Glutamate (mGluR1) agonist | |||
| 0.015 | 0.005 | 0.015 | Glutamate (mGluR6) agonist | |||
| 0.013 | 0.003 | 0.013 | DNA topoisomerase III inhibitor | |||
| 0.057 | 0.048 | 0.057 | Cyclin D1 inhibitor | |||
| 0.067 | 0.058 | 0.067 | Epoxide hydrolase inhibitor | |||
| 0.068 | 0.059 | 0.068 | Phospholipase D inhibitor | |||
| 0.123 | 0.115 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.033 | 0.025 | 0.033 | HCV polyprotein inhibitor | |||
| 0.022 | 0.014 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.081 | 0.074 | 0.081 | Potassium channel (Ca-activated) activator | |||
| 0.024 | 0.016 | 0.028 | Adenosine A1 receptor agonist | 0.028 0.013 CID_154699675 | CID_154699675 | |
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | 0.016 0.012 CID_154699675 | ||
| 0.061 | 0.053 | 0.061 | Kallikrein 7 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Adenosine A2a receptor agonist | |||
| 0.024 | 0.018 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.021 | 0.015 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.022 | 0.016 | 0.022 | Glutamate (mGluR1a) agonist | |||
| 0.026 | 0.021 | 0.026 | Leukotriene B4 receptor 1 antagonist | |||
| 0.022 | 0.018 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.038 | 0.034 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.053 | 0.049 | 0.053 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.049 CID_154699675 | ||
| 0.031 | 0.028 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.032 | 0.029 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.01 | 0.007 | 0.017 | Purinergic P2Y2 agonist | 0.017 0.002 CID_154699675 | CID_154699675 | |
| 0.029 | 0.026 | 0.029 | Caspase 6 inhibitor | |||
| 0.086 | 0.083 | 0.086 | Urease inhibitor | |||
| 0.016 | 0.014 | 0.016 | Aminopeptidase A inhibitor | |||
| 0.014 | 0.012 | 0.014 | Integrin beta6 antagonist | |||
| 0.144 | 0.142 | 0.144 | Dyrk kinase inhibitor | |||
| 0.04 | 0.038 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.054 | 0.052 | 0.054 | Acetylcholine M5 receptor antagonist | |||
| 0.019 | 0.018 | 0.019 | Prostaglandin EP2 agonist | |||
| 0.057 | 0.056 | 0.057 | Leukotriene antagonist | |||
| 0.087 | 0.086 | 0.21 | Monophenol monooxygenase inhibitor | 0.21 0.031 CID_154699675 | CID_154699675 | |
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.002 | 0.004 | 0.004 | Purinergic P2Y6 agonist | 0.004 0.002 CID_154699675 | CID_154699675 | |
| 0.086 | 0.093 | 0.267 | AMP-activated protein kinase stimulant | 0.267 0.006 CID_154699675 | CID_154699675 | |
| 0.185 | 0.194 | 0.311 | Vasodilator, peripheral | 0.311 0.091 CID_154699675 | CID_154699675 | |
| 0.013 | 0.022 | 0.02 | Telomerase stimulant | 0.02 0.007 CID_154699675 | CID_154699675 | |
| 0.082 | 0.091 | 0.155 | Mediator release inhibitor | 0.155 0.026 CID_154699675 | CID_154699675 | |
| 0.04 | 0.052 | 0.096 | Aldose reductase inhibitor | 0.096 0.019 CID_154699675 | CID_154699675 | |
| 0.015 | 0.028 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_154699675 | CID_154699675 | |
| 0.021 | 0.033 | 0.096 | Sodium/glucose cotransporter 2 inhibitor | 0.096 0.003 CID_154699675 | CID_154699675 | |
| 0.117 | 0.137 | 0.14 | CC chemokine 6 receptor antagonist | 0.14 0.04 CID_154699675 | CID_154699675 | |
| 0.151 | 0.177 | 0.591 | Hypoglycemic | 0.591 0.009 CID_154699675 | CID_154699675 | |
| 0.019 | 0.047 | 0.083 | Sodium/glucose cotransporter inhibitor | 0.083 0.003 CID_154699675 | CID_154699675 | |
| 0.005 | 0.033 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_154699675 | CID_154699675 | |
| 0.005 | 0.033 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_154699675 | CID_154699675 | |
| 0.027 | 0.058 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.018 CID_154699675 | CID_154699675 | |
| 0.051 | 0.084 | 0.099 | Na+ K+ transporting ATPase inhibitor | 0.099 0.032 CID_154699675 | CID_154699675 | |
| 0.013 | 0.051 | 0.042 | Squalene synthetase inhibitor | 0.042 0.017 CID_154699675 | CID_154699675 | |
| 0.124 | 0.169 | 0.298 | Hypolipemic | 0.298 0.049 CID_154699675 | CID_154699675 | |
| 0.019 | 0.071 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_154699675 | CID_154699675 | |
| 0.073 | 0.126 | 0.201 | DNA polymerase I inhibitor | 0.201 0.028 CID_154699675 | CID_154699675 | |
| 0.072 | 0.136 | 0.179 | Alkylator | 0.179 0.033 CID_154699675 | CID_154699675 | |
| 0.009 | 0.074 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_154699675 | CID_154699675 | |
| 0.17 | 0.248 | 0.488 | Interleukin 2 agonist | 0.488 0.009 CID_154699675 | CID_154699675 | |
| 0.216 | 0.297 | 0.328 | Caspase 9 stimulant | 0.328 0.165 CID_154699675 | CID_154699675 | |
| 0.061 | 0.144 | 0.21 | Transcription factor NF kappa B stimulant | 0.21 0.008 CID_154699675 | CID_154699675 | |
| 0.03 | 0.133 | 0.086 | Glucose-6-phosphate translocase inhibitor | 0.086 0.009 CID_154699675 | CID_154699675 | |
| 0.064 | 0.184 | 0.1 | Phosphodiesterase 6D inhibitor | 0.1 0.052 CID_154699675 | CID_154699675 | |
| 0.021 | 0.16 | 0.06 | Microtubule stabilization | 0.06 0.014 CID_154699675 | CID_154699675 | |
| 0.023 | 0.168 | 0.112 | Protein kinase C eta inhibitor | 0.112 0.014 CID_154699675 | CID_154699675 | |
| 0.102 | 0.248 | 0.642 | Antioxidant | 0.642 0.009 CID_154699675 | CID_154699675 | |
| 0.055 | 0.202 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.047 CID_154699675 | CID_154699675 | |
| 0.038 | 0.189 | 0.065 | Lipocortins synthesis agonist | 0.065 0.028 CID_154699675 | CID_154699675 | |
| 0.006 | 0.172 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_154699675 | CID_154699675 | |
| 0.062 | 0.233 | 0.229 | Cell adhesion inhibitor | 0.229 0.018 CID_154699675 | CID_154699675 | |
| 0.12 | 0.306 | 0.379 | Peptidyltransferase inhibitor | 0.379 0.009 CID_154699675 | CID_154699675 | |
| 0.008 | 0.199 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154699675 | CID_154699675 | |
| 0.072 | 0.272 | 0.277 | NOS3 expression enhancer | 0.277 0.021 CID_154699675 | CID_154699675 | |
| 0.022 | 0.273 | 0.072 | Factor IXa inhibitor | 0.072 0.019 CID_154699675 | CID_154699675 | |
| 0.01 | 0.266 | 0.186 | Antineoplastic antibiotic | 0.186 0.024 CID_154699675 | CID_154699675 | |
| 0.038 | 0.303 | 0.317 | Lipid peroxidase inhibitor | 0.317 0.017 CID_154699675 | CID_154699675 | |
| 0.035 | 0.311 | 0.276 | Thrombolytic | 0.276 0.028 CID_154699675 | CID_154699675 | |
| 0.007 | 0.288 | 0.059 | Protein 30S ribosomal subunit inhibitor | 0.059 0.006 CID_154699675 | CID_154699675 | |
| 0.044 | 0.331 | 0.252 | Anticoagulant | 0.252 0.038 CID_154699675 | CID_154699675 | |
| 0.025 | 0.341 | 0.134 | Topoisomerase II inhibitor | 0.134 0.057 CID_154699675 | CID_154699675 | |
| 0.052 | 0.369 | 0.158 | P-glycoprotein inhibitor | 0.158 0.105 CID_154699675 | CID_154699675 | |
| 0.025 | 0.341 | 0.104 | DNA intercalator | 0.104 0.069 CID_154699675 | CID_154699675 | |
| 0.02 | 0.358 | 0.242 | Topoisomerase I inhibitor | 0.242 0.018 CID_154699675 | CID_154699675 | |
| 0.042 | 0.425 | 0.461 | Nitric oxide antagonist | 0.461 0.019 CID_154699675 | CID_154699675 | |
| 0.03 | 0.456 | 0.173 | Toll-Like receptor 4 antagonist | 0.173 0.011 CID_154699675 | CID_154699675 | |
| 0.031 | 0.477 | 0.256 | Platelet antagonist | 0.256 0.07 CID_154699675 | CID_154699675 | |
| 0.012 | 0.466 | 0.075 | Antibiotic Aminoglycoside-like | 0.075 0.005 CID_154699675 | CID_154699675 | |
| 0.036 | 0.492 | 0.478 | Platelet adhesion inhibitor | 0.478 0.006 CID_154699675 | CID_154699675 | |
| 0.012 | 0.473 | 0.061 | Nitric oxide donor | 0.061 0.046 CID_154699675 | CID_154699675 | |
| 0.048 | 0.51 | 0.47 | Immunosuppressant | 0.47 0.041 CID_154699675 | CID_154699675 | |
| 0.042 | 0.536 | 0.264 | Angiogenesis inhibitor | 0.264 0.113 CID_154699675 | CID_154699675 | |
| 0.029 | 0.529 | 0.24 | Alpha-glucosidase inhibitor | 0.24 0.193 CID_154699675 | CID_154699675 | |
| 0.015 | 0.521 | 0.096 | Cell adhesion molecule inhibitor | 0.096 0.037 CID_154699675 | CID_154699675 | |
| 0.01 | 0.517 | 0.102 | Protein 50S ribosomal subunit inhibitor | 0.102 0.013 CID_154699675 | CID_154699675 | |
| 0.024 | 0.593 | 0.219 | Insulin secretagoues | 0.219 0.027 CID_154699675 | CID_154699675 | |
| 0.01 | 0.655 | 0.086 | Topoisomerase II alpha inhibitor | 0.086 0.049 CID_154699675 | CID_154699675 | |
| 0.014 | 0.857 | 0.373 | Immunomodulator | 0.373 0.052 CID_154699675 | CID_154699675 | |
| 0.015 | 0.944 | 0.263 | Caspase 3 stimulant | 0.263 0.102 CID_154699675 | CID_154699675 | |
| 0.005 | 0.938 | 0.361 | Tumour necrosis factor alpha release inhibitor | 0.361 0.035 CID_154699675 | CID_154699675 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |